Elekta is a leading innovator in precision radiation therapy, dedicated to ensuring that every patient has access to the best possible cancer care. With a global team of 4,700 employees, Elekta collaborates closely with healthcare professionals to develop sustainable, outcome-driven, and cost-efficient solutions that meet the evolving needs of patients. The company is committed to improving, prolonging, and saving lives through advanced technology and software, with over 6,000 hospitals worldwide relying on Elekta's products. Headquartered in Stockholm, Sweden, and present in more than 120 countries, Elekta is listed on Nasdaq Stockholm and strives to build hope for everyone dealing with cancer.